Efficacy and Safety of Tofacitinib in Rheumatoid Arthritis (RA): A Retrospective Study From Two Centers in Jeddah, Saudi Arabia

Background: Tofacitinib is the first Janus kinase (JAK) inhibitor approved for treating rheumatoid arthritis (RA). Several clinical trials have evaluated the safety and effectiveness of tofacitinib in adult patients with moderately to severely active RA. Real-world studies provide invaluable insight...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzahrani, Zeyad, Alhazmi, Ahmed, Almalki, Hanan, Aljehani, Noura, Dumyati, Mohammed, Alabdali, Hadeel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2022
Materias:
Rheumatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813543/
https://www.ncbi.nlm.nih.gov/pubmed/36620821
http://dx.doi.org/10.7759/cureus.32240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9813543/
https://www.ncbi.nlm.nih.gov/pubmed/36620821
http://dx.doi.org/10.7759/cureus.32240

Ejemplares similares